This website uses cookies to improve functionality and tailor your browsing experience.
If you continue to use this website, you agree to the placing of cookies on your device.
Please refer to our cookies policy contained in our Privacy Policy for more information.
Accept

Intellectual disabilities & economic evaluations

Could people with intellectual disabilities be discriminated against in economic evaluations of health-related interventions?

Traditional methods used in economic evaluations reward interventions with big improvements in quality of life and survival. But how do they fare in contexts where obtaining large improvements may not be the primary aim of the interventions? This is likely to be the case for interventions for people with intellectual disabilities.

Measuring the effects of interventions for people with intellectual disabilities

Economic evaluations are used to determine which interventions bring the highest value for money in a healthcare system like the NHS. They are based on the concept of cost-effectiveness, which implies calculating and comparing the costs and benefits of alternative healthcare interventions. Calculating the benefits typically means estimating how well and how long people will live as a result of the interventions being tested.

However, this approach could underestimate the value of interventions where large gains in quality of life and life expectancy are not expected. For people with intellectual disabilities maintaining or even slightly improving health and quality of life may still be key.

To explore what the literature says on how the effects of interventions for people with intellectual disabilities can be measured in economic evaluations, the MIDAS Theme in the ARC North West Coast has recently undertaken a new systematic review.

Intellectual disabilities: what are they?

In our systematic review we used the definition from the American Association on Intellectual and Developmental Disabilities which explains intellectual disabilities in terms of an individual’s limitations in both intellectual functioning and adaptive behaviour. Another definition, provided by Mencap, adds more details:

“A learning disability* is a reduced intellectual ability and difficulty with everyday activities – for example household tasks, socialising or managing money – which affects someone for their whole life. People with a learning disability tend to take longer to learn and may need support to develop new skills, understand complicated information and interact with other people”

Having an intellectual disability is often associated with other conditions, such as Down syndrome, autism, epilepsy, and cerebral palsy. In the UK alone, 1.5 million people have an intellectual disability (approximately 2% of the UK population) (Mencap, 2022); of these, roughly 350,000 are children or adolescents. The prevalence of intellectual disabilities calls for using appropriate methods to determine the cost-effectiveness of the interventions for this population. Not doing so would increase the risk of underestimating the value of these interventions, and could indirectly discriminate against people with intellectual disabilities.

Economic evaluations need a tailored approach to intellectual disabilities

From our review we found evidence-based solutions to challenges in economic evaluations of interventions for people with intellectual disabilities.

1. Interventions for people with intellectual disabilities are likely to have multiple impacts, which extend beyond the health and quality of life of the individual to those of their caregivers and family members.

To capture these multiple impacts, economic evaluations should consider adopting a wide perspective and considering any spillover effects.

2. Typical instruments used in economic evaluations intend to capture what the generic health state of a person looks like. As such, they may not delve too much into specific dimensions which are relevant for people with intellectual disabilities (e.g. social relationships and outward behaviour).

These instruments are also not easily applicable to people with intellectual disabilities. They include questions which assume a degree of health-related knowledge and require the respondent to be able to rank how problematic their own health state is.

3. Problems do not stop with describing a person’s health state, but also to put a value on this – which is key in economic evaluations. Techniques normally rely on the general population assigning a value to different health states, rather than on people with intellectual disabilities. One of the reasons given as to why this is done is that the general population funds the healthcare system through taxes, and should therefore have a say in the process. However, it is likely that the general population will lack a full understanding of the health and quality of life of a person living with intellectual disabilities. This approach also implies that people with intellectual disabilities may not be able to assign values and/or that their views are unimportant.

Instruments and techniques to describe and put values over health states need to be bespoke to people with intellectual disabilities.

4. After placing values on health states, the next step in economic evaluations is calculating the quality-adjusted life years or QALYs. QALYs are calculated by multiplying the value of a particular health state by the time people spend in that health state. Thus, they combine the health and survival gains that patients get from receiving an intervention. Since they are very intuitive, QALYs are used to compare the value of interventions across different health areas.

(To find out more about QALYs, do watch our vlog)

It goes without saying that if the QALYs are estimated using generic instruments to describe health states and using techniques relying on the general population valuing these health states, they are unsuitable for capturing the characteristics and preferences of people with intellectual disabilities.

QALYs informed by bespoke instruments and techniques to describe and value health states of people with intellectual disabilities should be used in economic evaluations.

More research involving people with intellectual disabilities and their caregivers is needed to put a correct value on interventions for people with intellectual disabilities

New instruments, like the Recovering Quality of Life (ReQoL-10), suitable for evaluating mental healthcare interventions have emerged, and could be used to evaluate interventions with people with intellectual disabilities. There are promising signs that these new instruments may help minimise potential discriminations against interventions for people with intellectual disabilities. However, more research is needed to test new instruments and techniques in this population.

At the end of the day, if bespoke methods are not available nor used, the value of interventions for people with intellectual disabilities is likely to be underestimated, to the detriment of these individuals, their caregivers and families.

Footnote: *The Mencap definition uses the term ‘learning disability’, which is another term for ‘intellectual disability’; ‘intellectual disability’ is the internationally recognised term.

Read the full review here: https://onlinelibrary.wiley.com/doi/full/10.1111/jar.13056

Reference:
Benedetto, V., Filipe, L., Harris, C., Tahir, N., Doherty, A., & Clegg, A. (2022). Outcome measures for economic evaluations and cost‐effectiveness analyses of interventions for people with intellectual disabilities: A methodological systematic review. Journal of Applied Research in Intellectual Disabilities.

Authors of this summary:
• Dr Valerio Benedetto: Methodological Innovation, Development, Adaptation & Support (MIDAS) Theme, NIHR Applied Research Collaboration North West Coast (ARC NWC); Applied Health Research hub, University of Central Lancashire (UCLan).
• Dr Luís Filipe: MIDAS Theme, NIHR ARC NWC; Faculty of Health & Medicine, Lancaster University.
• Catherine Harris: MIDAS Theme, NIHR ARC NWC; Applied Health Research hub, UCLan.
• Naheed Tahir: Public Advisers’ Forum, NIHR ARC NWC.
• Dr Alison Doherty: MIDAS Theme, NIHR ARC NWC; Applied Health Research hub, UCLan.
• Professor Andrew Clegg: MIDAS Theme, NIHR ARC NWC; Applied Health Research hub, UCLan.

Contact for further information:
Dr Valerio Benedetto
ARCNWC-MIDAS@uclan.ac.uk
Twitter: @valesschloss @arc_nwc


CROSS CUTTING THEMES

Skip to content